C3 management cannot provide any further guidance as to the reasons for TGA indicating their intention to reject ReCell for product approval in Australia. The letter received from TGA was brief and only outlined that there are some issues.
CCE Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held
